A purple and pink letter v on a white background.
October 29, 2018

How Multi-Treatment Platforms Can Help Your Aesthetics Clinic Grow

The American Society of Plastic Surgeons reported that in 2017, growth in the demand for non-invasive aesthetics treatments outpaced the demand for surgical treatments by nearly 8 to 1. With consumers appearing to lean more toward non-surgical procedures as their first choice, it’s only fitting to invest in this area, but which treatments should your aesthetics clinic offer? Guessing which specific trends might stick for years to come can be a difficult game to play, so why not invest in a multi-treatment platform that covers multiple in-demand procedures instead? Consider the following benefits to determine if this is the right choice for your aesthetics clinic.

Benefits of a Multi-Treatment Medical Aesthetics Device

Easily Adapt to Meet Consumers’ Changing Demands

Soft tissue fillers, chemical peels, laser hair removal, and microdermabrasion were among the most popular non-surgical aesthetics treatments in 2016. However, from 2016 to 2017, the top five non-surgical procedures that saw the greatest increase were micro-ablative skin resurfacing (99.5% increase), ablative skin resurfacing (29.2%), fat reduction (24.7%), chemical peels (15.9%), and skin tightening treatments (15.1%). So, while some non-surgical or minimally invasive treatment options appear to maintain their popularity, there are growing opportunities in a range of non-surgical treatments.

Opting for a multi-treatment aesthetics device offers the opportunity to easily pivot to meet consumers’ changing demands—you can simply update and refocus your marketing campaigns to better promote the treatments gaining in popularity without having to purchase any new equipment for your clinic. Without a multi-treatment device, this switch in marketing and service offerings would cost your clinic much more time and money. Adding ongoing aesthetics education to the mix for all of your treatment offerings can also help ensure your clinic is always a step ahead of competitors.

Offer Optimal Results with Complementary Uses

Investing in a multi-treatment platform, particularly one that supports complementary uses of energy-based procedures, can help to improve your clinical outcomes and show off your expertise with quality before-and-after photos. Consider TriBella ™ treatments, exclusive to the Venus Versa™ multi-application platform. This treatment protocol allows providers to deliver a three-step facial rejuvenation treatment that simultaneously enhances skin’s tone, tightness, and texture. Each TriBella™ session utilizes different applicators with distinct modes of action to provide three consecutive treatments: photorejuvenation , anti-aging , and skin resurfacing . Clinics using Venus Versa™ may choose to offer the combined TriBella™ protocol or deliver each treatment separately, depending on the patient’s aesthetic goals.

Build Up Practice Service Offerings with Less Capital

A multi-treatment medical aesthetics device often requires various applicators for different types of treatments. For example, a device may require two different applicators to perform skin resurfacing and photorejuvenation treatments. While applicators will be an additional cost, it is much more manageable to scale or expand your clinic’s services by purchasing applicators rather than complete devices. As well, acquiring a multi-treatment platform via Venus Concept’s industry-unique subscription acquisition model can help by maintaining equal cost payments to better manage expenses as your clinic grows.

Make Better Use of Limited Office Space

Whether you’re spring cleaning your office or simply looking to upgrade the layout, space-saving devices can offer significant benefits for aesthetics clinics with a smaller square footage. Rather than accommodating several devices to fulfill your list of offered services in several rooms, a multi-treatment platform can allow for one treatment room, opening up further space for other endeavors that can assist with business growth. Consider using the extra space to provide more room for patient comfort to improve their experience, a staff relaxation room to raise team morale, or a dedicated space for before-and-after photos to improve your marketing materials. Regardless, an upgrade to a single, versatile multi-treatment system can offer benefits beyond offering the most in-demand services—it can enhance many other aspects of your medical aesthetics business as well.

To learn more about Venus Concept’s most versatile multi-application platform or how you can upgrade your Venus Versa™ to offer a broader range of services, contact an expert today.

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.